FDA OKs Nusinersen, First Drug for Spinal Muscular Atrophy FDA OKs Nusinersen, First Drug for Spinal Muscular Atrophy
Nusinersen is approved to treat children and adults with spinal muscular atrophy.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news
More News: Brain | Children | Drugs & Pharmacology | Neurology | Neurosurgery | Spinal Muscular Atrophy